Skip to main content
. 2015 Dec 28;10:179–273. doi: 10.1111/j.1469-0691.2004.0902c.x

Table.

Clinical efficacy, ITT, CE and ME population [N (%)]

LZD VAN 95% CI** P-value**
ITT
 Global 439/476 (92.2) 402/454 (88.5) −0.11, 7.47 0.0565
 EU* 37/40 (92.5) 34/42 (80.9)
CE
 Global 436/462 (94.4) 394/436 (90.4) 0.53, 7.48 0.0234
 EU* 37/39 (94.9) 33/39 (84.6)
ME
 Global 312/330 (94.5) 278/310 (89.7) 0.69, 9.05 0.0218
 EU* 26/28 (92.8) 28/33 (84.8)
*

Included Portugal, Spain, and United Kingdom.

**

CI for global is for difference LZD - VAN, EU not sufficiently powered for analysis.